Intelligent Medical Imaging is currently inviting global submissions for its first three issues. It is our pleasure to extend an invitation for you to contribute to the journal.
We welcome submissions across fundamental, translational, and clinical research focusing on the application of AI, data science, and advanced computing technologies in all modalities of medical imaging (e.g., MRI, CT, X-ray, Ultrasound, Pathology, Nuclear Medicine, PET).
Key areas of interest for submissions include:
· Artificial Intelligence (AI) and Deep Learning for Imaging
· Computer-Aided Diagnosis (CAD) and Clinical Decision Support Systems (CDSS)
· Imaging Informatics and Big Data
· Advanced Imaging Technologies
· Clinical Application and Translation
Types of Manuscripts Accepted: Original Article, Review Article, Case Report, Study Protocol, Communication, Rapid Report, Commentary, Letter, etc.
Submitting to IMI
Online submission: https://mc.manuscriptcentral.com/imimaging
Email submission: editor@IMedImaging.org
Article Processing Charges Policy
Notably, Article Processing Charges (APCs) will be waived for manuscripts accepted for the first three issues in 2026. Starting from the 4th issue in 2026, standard APCs ($500 USD per accepted manuscript) will take effect, with discounted rates for early-career researchers and authors from low-income countries.
Invitation to Recommend Editorial Board Members and Youth Editorial Board Members
In addition to manuscript submissions, we are seeking to expand our Editorial Board and Youth Editorial Board. We would greatly appreciate your recommendations for suitable candidates for this important role. Ideal candidates should have:
• Extensive research experience in Intelligent Medical Imaging
• Experience in peer-reviewing
• A commitment to upholding the quality and reputation of the journal
If you have any suitable recommendations, please send their names, affiliations, contact details, and a brief introduction to editor@IMedImaging.org.
We invite any questions you may have about our journal and look forward to your positive response.